Gboxin

Overview

Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F 0 F 1 ATP synthase . Antitumour activity.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Oxidative Phosphorylation | Products > Signaling Pathways > ATP Synthase | Products > Signaling Pathways > Mitochondrial Metabolism

Product Information

• Catalog No.: HY-111651
• CAS No.: 2101315-36-8
• Molecular Formula: C22H33ClN2O2
• Molecular Weight: 392.96
• Purity: 99.03%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.17 mg/mL (5.52 mM); Clear solution
• Availability: In-stock

Source

Original product source